About Argos Therapeutics
Argos Therapeutics is a company based in Durham (United States) founded in 1997 was acquired by Genexine in February 2019. It operates as a Commission-Based. Argos Therapeutics has raised $169.65 million across 15 funding rounds from investors including SVB, ABN AMRO and Edelman Financial Engines. The company has 40 employees as of December 31, 2022. Argos Therapeutics offers products and services including Tai Xiu Online. Argos Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Durham, United States
- Employees 40 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$1.9 M101as on Dec 31, 2017
-
Net Profit
$-40.58 M23as on Dec 31, 2017
-
EBITDA
$-62.46 M-19as on Dec 31, 2017
-
Total Equity Funding
$169.65 M (USD)
in 15 rounds
-
Latest Funding Round
$6 M (USD), Post-IPO
Jun 16, 2017
-
Investors
SVB
& 29 more
-
Employee Count
40
as on Dec 31, 2022
-
Acquired by
Genexine
(Feb 13, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Argos Therapeutics
Argos Therapeutics offers a comprehensive portfolio of products and services, including Tai Xiu Online. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Online Tai Xiu game platform is provided for users.
Unlock access to complete
Funding Insights of Argos Therapeutics
Argos Therapeutics has successfully raised a total of $169.65M across 15 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Post-IPO — $6.0M
-
First Round
First Round
(01 Jun 2000)
- Investors Count 28
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Post-IPO - Argos Therapeutics | Valuation |
investors |
|
| Mar, 2016 | Amount | Post-IPO - Argos Therapeutics | Valuation |
investors |
|
| Apr, 2015 | Amount | Post-IPO - Argos Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Argos Therapeutics
Argos Therapeutics has secured backing from 30 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, ABN AMRO and Edelman Financial Engines. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location | |
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Argos Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Argos Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Argos Therapeutics Comparisons
Competitors of Argos Therapeutics
Argos Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Argos Therapeutics
Frequently Asked Questions about Argos Therapeutics
When was Argos Therapeutics founded?
Argos Therapeutics was founded in 1997 and raised its 1st funding round 3 years after it was founded.
Where is Argos Therapeutics located?
Argos Therapeutics is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is Argos Therapeutics a funded company?
Argos Therapeutics is a funded company, having raised a total of $169.65M across 15 funding rounds to date. The company's 1st funding round was a Post-IPO of $10M, raised on Jun 01, 2000.
How many employees does Argos Therapeutics have?
As of Dec 31, 2022, the latest employee count at Argos Therapeutics is 40.
What is the annual revenue of Argos Therapeutics?
Annual revenue of Argos Therapeutics is $1.9M as on Dec 31, 2017.
What does Argos Therapeutics do?
A platform for online Tai Xiu gambling is provided by Argos Therapeutics. Various betting options and promotional offers are featured for users. The service targets players in Vietnam and other regions with a focus on secure transactions. Multiple payment methods including cryptocurrency are supported for user convenience. The platform is designed to cater to a growing community of online gamblers.
Who are the top competitors of Argos Therapeutics?
Argos Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Argos Therapeutics offer?
Argos Therapeutics offers Tai Xiu Online.
Who are Argos Therapeutics's investors?
Argos Therapeutics has 30 investors. Key investors include SVB, ABN AMRO, Edelman Financial Engines, NIH, and BD.